| Literature DB >> 347279 |
W G Thilly, J G Deluca, H Hoppe, B W Penman.
Abstract
Mutants of a diploid human lymphoblast line resistant to 6-thioguanine (6TG) appear 6--16 generations after treatment with any of a diverse group of mutagents: methylnitrosourea (MNU), methylnitrosoguanidine (MNNG), ICR-191, 5-bromodeoxyuridine (BUdR). A hypothesis is advanced that expression of the 6-thioguanine-resistant state may require the removal of essentially all pre-existing hypoxanthine--guanine phosphoribosyl transferase (HGPRT) molecules via division, dilution, and protein turnover. Design of protocols for quantitative mutation assays requires attention to this phenomenon.Entities:
Mesh:
Substances:
Year: 1978 PMID: 347279 DOI: 10.1016/0027-5107(78)90068-4
Source DB: PubMed Journal: Mutat Res ISSN: 0027-5107 Impact factor: 2.433